Please provide your email address to receive an email when new articles are posted on . The incidence of Kaposi’s sarcoma and related death in East Africa has not improved in the last 5 years. In a ...
Dirk Dittmer, PhD, and colleagues have developed a model of Kaposi sarcoma could be key to the development of new drugs to treat the disease. Kaposi sarcoma is the most common cancer in people living ...
Kaposi sarcoma is a cancer that causes skin blotches and tumors. It has three skin stages, and the patch stage is one of them. The human herpesvirus 8 (HHV8) causes Kaposi sarcoma. HHV8 may be ...
Author(s)Amy Paturel, M.S., M.P.H. A rare virus coupled with an ailing immune system can lead to Kaposi’s sarcoma. Restoring immune function can help fight it. Alex C.* was a teenager in 2007 when ...
A study has identified a binding protein in cancer cell's nucleus, known as CHD4, as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's immune ...
A team of UC Davis researchers has identified a protein in the cancer cell's nucleus as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's ...
Kaposi sarcoma, a type of vascular cancer once only seen in elderly people of Jewish or Mediterranean descent, is one of the two most common opportunistic diseases associated with AIDS. Its spread, ...
Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study Over time, KS and NHL occurred at ...
UK participants in the Concorde (1994), Delta (1996) and Alpha (1996) randomised controlled trials of antiretroviral therapy for HIV infection were followed for the development of AIDS-defining ...
Researchers in the UK have developed a prognostic index to predict survival in individuals with AIDS-associated Kaposi's sarcoma. Survival varies considerably between patients with this condition, and ...
Kaposi sarcoma is a slow-growing vascular tumor localized to skin, but which spreads to internal viscera in 40% of immunosuppressed post-transplant patients. Kaposi sarcoma results from either primary ...
Researchers have developed a model of Kaposi sarcoma that could expedite the development of new drugs to treat the disease, which is the most common cancer in people living with HIV. Researchers at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback